Kuwaiti Health
Kuwaiti Health

The Assistant Undersecretary for Drug and Food Control Affairs, Dr. Abdullah Al-Badr, announced the issuance of a license to use under the emergency clause of the drug Bamlanivimab to treat Corona patients.

 

In detail, this bitumen is used to treat mild to moderate cases of Covid-19 in adult patients and children over 12 years of age who have risk factors that make them more vulnerable to the deterioration of their disease.

Also, an emergency use license has been issued for Barcitinib for use as an additive drug to Remdesivir to treat cases of Covid-19 in adult patients and children over two years who are receiving hospital treatment and who need oxygen or a ventilator.

Dr. Al-Badr affirmed the keenness of the drug and food control sector in the Ministry of Health to provide the best and latest approved treatments for Covid-19 patients in the State of Kuwait.